Header cover image

Japanese Pharmaceuticals & Biotech Your first investment

Results

8

0 new
Based on available information up to March 12, 2025, Donald Trump’s plans for oil and gas focus on maximizing U.S. production, reducing regulatory barriers, and prioritizing fossil fuels as a cornerstone of his energy policy. Here’s a concise overview of his intentions: Boost Production and Permitting: Trump has pledged to "unleash" American oil and gas by accelerating permitting processes. On his first day in office (January 20, 2025), he signed executive orders declaring a "national energy emergency" to fast-track approvals for energy infrastructure like pipelines, refineries, and power plants. This includes expanding drilling on federal lands and offshore areas, reversing Biden-era restrictions.

8 companies

Takeda Pharmaceutical

Market Cap: JP¥6.7t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

4502

JP¥4,419.00

7D

3.4%

1Y

7.1%

Astellas Pharma

Market Cap: JP¥2.6t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

4503

JP¥1,458.00

7D

5.5%

1Y

-6.4%

Shionogi

Market Cap: JP¥2.1t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

4507

JP¥2,457.00

7D

2.2%

1Y

0.4%

Eisai

Market Cap: JP¥1.2t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

4523

JP¥4,271.00

7D

4.9%

1Y

-34.7%

Kyowa Kirin

Market Cap: JP¥1.1t

Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.

4151

JP¥2,191.00

7D

-0.4%

1Y

-17.9%

Ono Pharmaceutical

Market Cap: JP¥783.0b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

4528

JP¥1,667.00

7D

2.9%

1Y

-27.7%

Tsumura

Market Cap: JP¥325.7b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

4540

JP¥4,301.00

7D

0.8%

1Y

15.0%

Nippon Shinyaku

Market Cap: JP¥251.7b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

4516

JP¥3,735.00

7D

3.2%

1Y

-14.9%